Phase II Study of Cisplatin Plus Etoposide and Bevacizumab for Previously Untreated, Extensive-Stage Small-Cell Lung Cancer: Eastern Cooperative Oncology Group Study E3501 von Horn, Leora, Dahlberg, Suzanne E, Sandler, Alan B, Dowlati, Afshin, Moore, Dennis F, Murren, John R, Schiller, Joan H

Volltext

Phase I/II study of inhaled doxorubicin combined with platinum-based therapy for advanced non-small cell lung cancer von Otterson, Gregory A, Villalona-Calero, Miguel A, Hicks, William, Pan, Xueliang, Ellerton, John A, Gettinger, Scott N, Murren, John R

Volltext

Phase 1 Study of Aflibercept Administered Subcutaneously to Patients with Advanced Solid Tumors von TEW, William P, GORDON, Michael, PSYRRI, Amanda, CEDARBAUM, Jesse M, SPRIGGS, David R, MURREN, John, DUPONT, Jakob, PEZZULLI, Sandra, AGHAJANIAN, Carol, SABBATINI, Paul, MENDELSON, David, SCHWARTZ, Lawrence, GETTINGER, Scott

Volltext

Phase I Study of Inhaled Doxorubicin for Patients with Metastatic Tumors to the Lungs von OTTERSON, Gregory A, VILLALONA-CALERO, Miguel A, KRAUT, Michael, MANI, Sridhar, MURREN, John R, SHARMA, Sunil, KRIS, Mark G, IMONDI, Anthony, GERBER, Mirjam, WHITE, Dorothy A, RATAIN, Mark J, SCHILLER, Joan H, SANDLER, Alan

Volltext

Surface-enhanced Raman spectral measurements of 5-fluorouracil in saliva von Farquharson, Stuart, Gift, Alan, Shende, Chetan, Inscore, Frank, Ordway, Beth, Farquharson, Carl, Murren, John

Volltext

Progress in the therapy of small cell lung cancer von Simon, Miklos, Argiris, Athanassios, Murren, John R.

Volltext

Phase I and Pharmacokinetic Study of Triapine, a Potent Ribonucleotide Reductase Inhibitor, Administered Daily for Five Days in Patients with Advanced Solid Tumors von MURREN, John, MODIANO, Manuel, CLAIRMONT, Caroline, LAMBERT, Paula, SAVARAJ, Niramol, DOYLE, Terry, SZNOL, Mario

Volltext

Metastatic myoepithelial carcinoma of the vulva treated with carboplatin and paclitaxel von Noronha, Vanita, Cooper, Dennis L, Higgins, Susan A, Murren, John R, Kluger, Harriet M

Volltext

Modulating multidrug resistance: can we target this therapy? von Murren, John R

Volltext

Further delineation of the continuous human neoplastic enterochromaffin cell line, KRJ-I, and the inhibitory effects of lanreotide and rapamycin von Kidd, Mark, Eick, Geeta N, Modlin, Irvin M, Pfragner, Roswitha, Champaneria, Manish C, Murren, John

Volltext

Phase II trial of weekly docetaxel/irinotecan combination in advanced pancreatic cancer von Burtness, Barbara, Thomas, Laurie, Sipples, Rebecca, McGurk, Meghan, Salikooti, Saritha, Christoforou, Maryanne, Mirto, Gayle, Salem, Ronald, Sosa, Julieann, Kloss, Robert, Rahman, Zia, Chung, Gina, Lacy, Jill, Murren, John R

Volltext

Comparison of Health-Related Quality of Life Questionnaires in Ambulatory Oncology von Cooley, Mary E., McCorkle, Ruth, George J. Knafl, Joan Rimar, Margaret J. Barbieri, Marianne Davies, John Murren

Volltext

Evaluation of irinotecan plus paclitaxel in patients with advanced non-small cell lung cancer von Murren, John R., Andersen, Nicolaj, Psyrri, Diamondo, Brandt, Deborah, Nadkarni, Rajani, Rose, Michal, Parisot, Nicole, Rosenfield, Arthur T., Pizzorno, Giuseppe, Zelterman, Daniel

Volltext

Phase I Dose Escalation Trial of Weekly Docetaxel Plus Irinotecan in Patients with Advanced Cancer von Bleickardt, Eric, Argiris, Athanassios, Rich, Randy, Blum, Kathi, McKeon, Anne, Tara, Harold, Zelterman, Daniel, Burtness, Barbara, Davies, Marianne J., Murren, John R.

Volltext

Camptothecin and taxane regimens for small-cell lung cancer von Kwong, Myron S, Bleickardt, Eric, Murren, John R

Volltext

A phase II study of topotecan and cyclophosphamide with G-CSF in patients with advanced small cell lung cancer von Hobdy, Erole M, Kraut, Eric, Masters, Gregory, Blum, Kathleen, McKeon, Anne, Byrd, Boyd, Davies, Marianne, Beaulieu, Nancy, Murren, John R

Volltext

Phase I Study of Perillyl Alcohol in Patients with Refractory Malignancies von Murren, John R., Pizzorno, Giuseppe, DiStasio, Susan A., McKeon, Anne, Peccerillo, Kathleen, Gollerkari, Ashwin, McMurray, Walter, Burtness, Barbara A., Rutherford, Thomas, Li, Xin, Ho, Peter T. C., Sartorelli, Alan

Volltext

Phase II trial of 9-aminocamptothecin as a 72-h infusion in cutaneous T-cell lymphoma von ARGIRIS, Athanassios, HEALD, Peter, KUZEL, Timothy, FOSS, Francine M, DISTASIO, Susan, COOPER, Dennis L, ARBUCK, Susan, MURREN, John R

Volltext

Therapy for Stage IIIA, IIIB and IV Non–Small Cell Lung Cancer von Kim, Tracy E, Murren, John R

Volltext

P-Glycoprotein Expression and Multidrug Resistance in Cutaneous T-cell Lymphoma von Jillella, Anand P., Murren, John R., Hamid, Khawaja K., Longley, B. Jack, Edelson, Richard L., Cooper, Dennis L.

Volltext